Dysmenorrhea
Pipeline by Development Stage
On Market (1)
Approved therapies currently available
Competitive Landscape
9 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 18 trials with date data
Clinical Trials (18)
Total enrollment: 11,689 patients across 18 trials
NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)
A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea
To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea
Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study
Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea
Efficacy and Safety Study of Lidocaine Vaginal Gel for Recurrent Dysmenorrhea (Painful Periods)
Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women
Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea
Research and Development of WPAPS Based on the Modern Technology of Traditional Chinese Medicine
Survey on Menstrual Symptoms, Health Related Quality of Life and Work Productivity in Patients Suffering From Pain During Menstruation (Dysmenorrhea) in Japan
Cooperative Adenomyosis Network
Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea
YAZ Post-marketing Surveillance in Japan
Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.